Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: DiaSorin S.p.A.

Capitalization 3.75B 4.34B 3.39B 3.24B 5.91B 401B 6.07B 40.06B 15.97B 192B 16.3B 15.96B 690B P/E ratio 2025 *
20.9x
P/E ratio 2026 * 18.2x
Enterprise value 4.29B 4.96B 3.87B 3.7B 6.75B 458B 6.94B 45.77B 18.24B 219B 18.62B 18.23B 788B EV / Sales 2025 *
3.57x
EV / Sales 2026 * 3.31x
Free-Float
37.75%
Yield 2025 *
1.76%
Yield 2026 * 1.83%
1 day-6.70%
1 week-7.10%
Current month-8.82%
1 month-12.32%
3 months+3.57%
6 months-18.95%
Current year-5.39%
1 week 64.92
Extreme 64.92
71.36
1 month 64.92
Extreme 64.92
74.7
Current year 64.92
Extreme 64.92
77.64
1 year 58.18
Extreme 58.18
101.6
3 years 58.18
Extreme 58.18
112.35
5 years 58.18
Extreme 58.18
208.8
10 years 44.5
Extreme 44.5
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO 55 01/01/2016
Corporate Officer/Principal 63 29/04/2022
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Change 5d. change 1-year change 3-years change Capi.($)
-6.70%-7.10%-34.60%-39.89% 4.37B
-1.10%-4.18%-16.74%+0.02% 13.07B
-3.04%-5.53%+106.15%+239.83% 11.87B
+0.15%+3.79%-10.81%-6.05% 6.19B
-1.77%+5.20%-21.73%+15.75% 5.38B
-0.46%-7.00% - - 5.24B
+10.00%+15.88%+38.41%+24.01% 3.25B
-0.37%-0.48%-16.26%-42.27% 2.93B
+0.05%-8.76%+88.81%-57.06% 2.61B
-1.40%+15.63%+36.38%+71.36% 2.08B
Average -0.46%+1.76%+18.85%+22.86% 5.7B
Weighted average by Cap. -1.10%+0.06%+21.09%+51.66%

Financials

2025 *2026 *
Net sales 1.2B 1.39B 1.09B 1.04B 1.89B 128B 1.95B 12.84B 5.12B 61.37B 5.22B 5.11B 221B 1.26B 1.46B 1.14B 1.09B 1.99B 135B 2.04B 13.48B 5.37B 64.46B 5.49B 5.37B 232B
Net income 181M 210M 164M 157M 286M 19.36B 294M 1.94B 772M 9.26B 788M 771M 33.35B 208M 241M 188M 180M 328M 22.23B 337M 2.22B 886M 10.63B 905M 886M 38.29B
Net Debt 535M 620M 483M 462M 843M 57.14B 866M 5.71B 2.28B 27.32B 2.33B 2.28B 98.41B 434M 502M 392M 374M 683M 46.29B 702M 4.63B 1.85B 22.13B 1.88B 1.84B 79.72B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2024, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Employees
3,242
Date Price Change Volume
11/03/26 64.92 -6.70% 562,895
10/03/26 69.58 +1.07% 267,276
09/03/26 68.84 -0.17% 326,543
06/03/26 68.96 +0.35% 235,826
05/03/26 68.72 -1.66% 212,432
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
69.58EUR
Average target price
79.89EUR
Spread / Average Target
+14.82%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW